22514-58-5 Usage
General Description
2-Bromo-6-benzothiazolecarboxylic acid is a chemical compound with the molecular formula C9H9BrN2O2S. It is a brominated benzothiazole derivative that is commonly used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. This chemical is a white to yellowish solid that is sparingly soluble in most organic solvents. It is known for its use in the preparation of a wide range of biologically active molecules and is often utilized in medicinal chemistry and drug discovery research. Additionally, 2-bromo-6-benzothiazolecarboxylic acid is also employed as a building block in the production of agrochemicals, dyes, and other specialty chemicals, making it a versatile compound with diverse applications in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 22514-58-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,5,1 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 22514-58:
(7*2)+(6*2)+(5*5)+(4*1)+(3*4)+(2*5)+(1*8)=85
85 % 10 = 5
So 22514-58-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H4BrNO2S/c9-8-10-5-2-1-4(7(11)12)3-6(5)13-8/h1-3H,(H,11,12)
22514-58-5Relevant articles and documents
BENZOTHIAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
-
Page/Page column 33-34, (2008/12/04)
The invention provides compounds of formula (1 ) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of AIk, AbI, Aurora-A, B-Raf, Bcr-Abl, BRK, BIk, Bmx, c-Kit, c-RAF, cSRC. CSK, FLTl, Fms, Fyn, JAK2, KDR, Lck, Lyn, PDGFRα, PDGFRβ, PKCα. p38 (p38 MAP kinase, SAPK2α), Src, SIK, Syk, Tie2 and TrkB kinases. FORMULE (I)
